The role of NAS in the changing nature of MS pathophysiology needs to be clarified, including whether NAS, like BDNF and other neurotrophins, activates p75NTR, which induces ceramide synthesis and is increased in glia of MS plaques [158]. The gene discussed is BDNF; the disease is myeloid sarcoma.